Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedAdded site revision note: v3.5.0; removed revision: v3.4.3.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.4.2; removed the previous funding-status notice (lapse in government funding) and Revision: v3.4.1.SummaryDifference0.4%

- Check72 days agoChange DetectedA banner notice about a lapse in government funding and NIH operations status was added, and the page version updated from 3.4.0 to 3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange DetectedGlossary display has been added to the page. Minor textual/capitalization tweaks were made (e.g., 'Met QC Criteria' vs 'met QC Criteria' and 'No FEAR Act Data' vs 'data'), and the revision is updated to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.